These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
65 related articles for article (PubMed ID: 3104195)
1. [Opsonophagocytic assay of monoclonal antibodies against Pseudomonas aeruginosa group I strain PA10115]. Ye DN; Wang BY; Yan RH; Wang CX; Dai BM Hua Xi Yi Ke Da Xue Xue Bao; 1986 Sep; 17(3):173-5. PubMed ID: 3104195 [No Abstract] [Full Text] [Related]
2. [Screening and identification of hybridomas--derived monoclonal antibodies to Pseudomonas aeruginosa strain PA 10115]. Ye DN; Wang CX; Wu SR; Yin QZ; Dai BM Sichuan Yi Xue Yuan Xue Bao; 1985 Mar; 16(1):15-8. PubMed ID: 3925582 [No Abstract] [Full Text] [Related]
3. [Screening and identification of hybridomas producing monoclonal antibodies against Pseudomonas aeruginosa strain PA II 10117 and strain PA IV 10119]. Ye DN; Shen RQ; Yan RH; Zhu G; Li SF; Dai BM Hua Xi Yi Ke Da Xue Xue Bao; 1987 Jun; 18(2):119-21. PubMed ID: 3114120 [No Abstract] [Full Text] [Related]
4. Human monoclonal antibodies against Pseudomonas aeruginosa lipopolysaccharide derived from transgenic mice containing megabase human immunoglobulin loci are opsonic and protective against fatal pseudomonas sepsis. Hemachandra S; Kamboj K; Copfer J; Pier G; Green LL; Schreiber JR Infect Immun; 2001 Apr; 69(4):2223-9. PubMed ID: 11254577 [TBL] [Abstract][Full Text] [Related]
5. Immune response of the mouse to gram-negative bacterial outer membrane extracts as assessed with monoclonal antibodies. Mackie EB; Longenecker BM; Rabin HR; Di Ninno VL; Bryan LE J Immunol; 1982 Aug; 129(2):829-32. PubMed ID: 6806385 [TBL] [Abstract][Full Text] [Related]
6. Systematic generation of antigen specific human monoclonal antibodies with therapeutical activities using active immunization. Lang AB; Fürer E; Senyk G; Larrick JW; Cryz SJ Hum Antibodies Hybridomas; 1990; 1(2):96-103. PubMed ID: 2129420 [TBL] [Abstract][Full Text] [Related]
7. Surface localization of Pseudomonas aeruginosa outer membrane porin protein F by using monoclonal antibodies. Mutharia LM; Hancock RE Infect Immun; 1983 Dec; 42(3):1027-33. PubMed ID: 6315589 [TBL] [Abstract][Full Text] [Related]
8. Phagocytosis and intracellular killing of mucoid and nonmucoid variants of Pseudomonas aeruginosa by polymorphonuclear leukocytes: effect of specific immune sera. Gościniak G; Maresz-Babczyszyn J; Grzybek-Hryncewicz K Arch Immunol Ther Exp (Warsz); 1984; 32(4):467-79. PubMed ID: 6442852 [TBL] [Abstract][Full Text] [Related]
9. Characterization of monoclonal antibodies to Pseudomonas aeruginosa type A flagellar antigen. Montie TC; Phillips D; Landsperger WJ Behring Inst Mitt; 1997 Feb; (98):424-33. PubMed ID: 9382766 [TBL] [Abstract][Full Text] [Related]
10. Monoclonal antibodies: technology and application to gram-negative infections. Young LS Infection; 1984; 12(4):303-8. PubMed ID: 6208152 [TBL] [Abstract][Full Text] [Related]
11. Use of monoclonal antibodies to protein F of Pseudomonas aeruginosa as opsonins for phagocytosis by macrophages. Battershill JL; Speert DP; Hancock RE Infect Immun; 1987 Oct; 55(10):2531-3. PubMed ID: 3115901 [TBL] [Abstract][Full Text] [Related]
12. [Establishment of hybridoma lines and protective study of monoclonal antibodies against lipid A of endotoxins]. Fu W; Xiao G; Yu P Zhonghua Yi Xue Za Zhi; 1995 Mar; 75(3):159-60, 190-1. PubMed ID: 7780823 [TBL] [Abstract][Full Text] [Related]
13. In vitro and in vivo functional activities of monoclonal antibodies reactive with Pseudomonas aeruginosa serogroup 6 lipopolysaccharides. Pollack M; Tao M; Akiyama M; Pier GB; Koles NL Antibiot Chemother (1971); 1991; 44():163-71. PubMed ID: 1801635 [No Abstract] [Full Text] [Related]
14. Immunoprotective human monoclonal antibodies against five major serotypes of Pseudomonas aeruginosa. Sawada S; Kawamura T; Masuho Y J Gen Microbiol; 1987 Dec; 133(12):3581-90. PubMed ID: 3141560 [TBL] [Abstract][Full Text] [Related]
16. Generation and characterization of a protective monoclonal antibody to Pseudomonas aeruginosa PcrV. Frank DW; Vallis A; Wiener-Kronish JP; Roy-Burman A; Spack EG; Mullaney BP; Megdoud M; Marks JD; Fritz R; Sawa T J Infect Dis; 2002 Jul; 186(1):64-73. PubMed ID: 12089663 [TBL] [Abstract][Full Text] [Related]
18. [Screening and identification of monoclonal antibodies against human neutrophil and detection of inhibiting opsonic phagocytic activity]. Xu L; Gao J; Wang B Hua Xi Yi Ke Da Xue Xue Bao; 1991 Mar; 22(1):21-3. PubMed ID: 1774029 [TBL] [Abstract][Full Text] [Related]
19. [Therapeutic human monoclonal antibodies directed to Pseudomonas aeruginosa]. Noguchi H Nihon Rinsho; 1991 Oct; 49(10):2446-51. PubMed ID: 1749102 [No Abstract] [Full Text] [Related]
20. [Investigation on the protection of mice from infection with Pseudomonas aeruginosa using monoclonal antibodies]. Ye DN; Wang CX; Yan RH; Dai BM; Ni HY Sichuan Yi Xue Yuan Xue Bao; 1985 Sep; 16(3):188-90. PubMed ID: 3939267 [No Abstract] [Full Text] [Related] [Next] [New Search]